Khan Nusrat, Arruabarrena Micaela María, Kim Dani J, Jiang Miao, Llibre-Rodriguez Juan J, Rodriguez-Salgado Ana M, Acosta Issac, Sosa Ana Luisa, Acosta Daisy, Jimenez-Velasquez Ivonne Z, Guerra Mariella, Salas Aquiles, López-Contreras Ricardo, Santana Dhara, Solorzano Joel, Jeyachandran Christina, Hesse Heike, Tanner Caroline, Prina Matthew, Llibre-Guerra Jorge J
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina.
Alzheimers Dement. 2025 Jul;21(7):e70371. doi: 10.1002/alz.70371.
This study aimed to determine the associations between parkinsonism and Parkinson's disease (PD) with cognitive impairment and dementia in a multi-country cohort in Latin America, using data from the 10/66 Dementia Research Group.
This population-based prospective cohort study was conducted in six Latin American countries, including 11,321 participants 65 years of age or older living in urban and rural areas.
At baseline, the prevalence of cognitive impairment in people with parkinsonism and PD was 33% and 26%, respectively. Parkinsonism (odds ratio [OR] 2.2 [95% confidence interval [CI] 1.9-2.6] and PD (OR 1.9 [95% CI 1.4-2.4]) were individually associated with baseline cognitive impairment and incident dementia. The pooled sub-hazard ratios for dementia in fixed-effect meta-analysis were 1.5 (95% CI 1.2-1.9) for parkinsonism and 1.5 (95% CI 1.0-2.2) for PD.
Parkinsonism and PD were cross-sectionally associated with cognitive impairment and prospectively associated with incident dementia. These findings underscore the importance of routine screening for cognitive impairment in individuals with parkinsonism and PD, to facilitate early detection and intervention strategies that mitigate adverse outcomes.
The present study is one of the first longitudinal investigations into the association of parkinsonism and Parkinson's disease (PD) with cognitive impairment and dementia incidence in Latin America. Parkinsonism and PD showed strong cross-sectional associations with cognitive impairment, with consistent estimates across countries, independent of demographic factors. Parkinsonism and PD were linked to a significantly higher incidence of dementia over a 4-year follow-up period. Findings emphasize the need for routine cognitive screening in Parkinsonism and PD.
本研究旨在利用10/66痴呆症研究小组的数据,确定拉丁美洲多国队列中帕金森综合征和帕金森病(PD)与认知障碍和痴呆症之间的关联。
这项基于人群的前瞻性队列研究在六个拉丁美洲国家进行,包括11321名65岁及以上生活在城市和农村地区的参与者。
在基线时,帕金森综合征和PD患者的认知障碍患病率分别为33%和26%。帕金森综合征(优势比[OR]2.2[95%置信区间[CI]1.9 - 2.6])和PD(OR 1.9[95%CI 1.4 - 2.4])分别与基线认知障碍和新发痴呆症相关。固定效应荟萃分析中痴呆症的合并亚风险比,帕金森综合征为1.5(95%CI 1.2 - 1.9),PD为1.5(95%CI 1.0 - 2.2)。
帕金森综合征和PD在横断面研究中与认知障碍相关,在前瞻性研究中与新发痴呆症相关。这些发现强调了对帕金森综合征和PD患者进行认知障碍常规筛查的重要性,以便于早期发现并采取干预策略减轻不良后果。
本研究是拉丁美洲首批关于帕金森综合征和帕金森病(PD)与认知障碍及痴呆症发病率关联的纵向调查之一。帕金森综合征和PD与认知障碍呈现出强烈的横断面关联,各国估计结果一致,且不受人口统计学因素影响。在4年的随访期内,帕金森综合征和PD与痴呆症的发病率显著升高有关。研究结果强调了对帕金森综合征和PD患者进行常规认知筛查的必要性。